血小板反应蛋白-1通过CD47促进皮肤T细胞淋巴瘤进展
本研究探讨TSP-1与CD47在皮肤T细胞淋巴瘤(CTCL)中的作用。CTCL肿瘤细胞及细胞系高表达CD47,部分由c-Myc诱导;TSP-1在皮损中表达升高且与疾病相关死亡风险增加相关。TSP-1通过CD47促进肿瘤细胞增殖、存活、迁移及体内生长,介导ERK1/2和AKT磷酸化及survivin表达。
要点
- CTCL肿瘤细胞高表达CD47,部分由c-Myc诱导。
- TSP-1在CTCL皮损中高表达,与疾病相关死亡风险增加相关。
- 阻断CD47/TSP-1相互作用可抑制CTCL肿瘤细胞增殖和存活。
核心结论
- CD47/TSP-1相互作用在CTCL进展中起重要作用,提示新的治疗策略。
研究设计与样本
- 研究采用流式细胞术和免疫组化分析CTCL肿瘤细胞及细胞系(Hut78、HH、MyLa)中CD47表达。
- 检测CTCL皮损中TSP-1 mRNA表达及Sézary综合征患者血清可溶性TSP-1水平。
- 通过抗CD47中和抗体或CD47敲低及TSP-1刺激实验评估功能。
主要发现
- CTCL肿瘤细胞和细胞系较正常CD4+ T细胞过表达CD47。
- CD47过表达部分由CTCL肿瘤细胞中c-Myc高表达诱导。
- CTCL皮损中TSP-1 mRNA水平高于正常皮肤,且与疾病相关死亡风险增加相关。
- 免疫组化显示TSP-1在CTCL肿瘤细胞上表达。
- Sézary综合征患者血清可溶性TSP-1水平显著升高。
临床怎么用
- 靶向CD47/TSP-1相互作用可能成为CTCL的新型治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CD47 is highly expressed on various hematopoietic malignancies, and enables cancer cells to avoid immunosurveillance. Its ligand, thromobospondin-1 (TSP-1) is a multifunctional protein, and CD47/TSP-1 interactions promote tumor progression in various malignancies. In this study, we investigated roles of TSP-1 and CD47 in cutaneous T-cell lymphoma (CTCL). Flow cytometric analysis and immunohistochemistry showed that CTCL tumor cells and CTCL cell lines (Hut78, HH, and MyLa cells) overexpressed CD47 compared with normal CD4+ T cells. Overexpression of CD47 was partially induced by high c-Myc expression in CTCL tumor cells. TSP-1 mRNA expression levels in CTCL lesional skin were higher than those in normal skin and correlated with increased risk of disease-related death. Moreover, TSP-1 was expressed on CTCL tumor cells by immunohistochemistry. Serum soluble TSP-1 levels in patients with Sézary syndrome were significantly elevated. TSP-1 promotes proliferation and survival of CTCL tumor cells, which is inhibited by anti-CD47 neutralizing antibody or CD47 knockdown. Stimulation with TSP-1 also induces cell migration and in vivo growth. These effects were mediated by phosphorylation of ERK1/2 and AKT and expression of survivin. Collectively, our findings prompt a novel therapeutic approach to CTCL based on discovery that CD47/TSP-1 interactions play important roles in progression of CTCL.
引用
- Kamijo H, Miyagaki T, Takahashi-Shishido N, et al. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47. Leukemia. 2019. PMID: 31712778. doi:10.1038/s41375-019-0622-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。